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Abstract
Individuals with schizophrenia demonstrate stable deficits in affect recognition. Similar deficits in
affect recognition have been observed in those who are at clinical high risk (CHR) of developing
psychosis. The current project aimed to longitudinally examine affect processing in CHR
individuals, to determine if affect processing predicted later conversion to psychosis and if affect
processing deficits were unique to those who met established criteria for prodromal syndromes.
The sample consisted of 172 CHR and 100 help-seeking individuals (HS) who were followed for
up to 24 months. All CHR individuals met the Criteria of Prodromal States (COPS) based on the
Structured Interview for Prodromal Symptoms (SIPS). The SIPS was used to determine
conversion to psychosis. Affect recognition was assessed using two facial affect recognition tasks
and a measure of affective prosody. In comparison to previously published data from non-
psychiatric controls, both CHR and HS groups demonstrated deficits on affect recognition. By 2
years 25 CHR participants converted to psychosis. Interestingly, there were no differences
between converters and non-converters on any affect recognition tasks. This is one of the first
studies to longitudinally examine affect processing and its relationship to later conversion to
psychosis in individuals at-risk for psychosis. While poorer affect recognition may be associated
with vulnerability for psychosis, the current results suggest that it may not be a marker of
developing a psychotic illness.
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1. Introduction
There is a growing interest in social cognition in schizophrenia, mainly due to its association
with poor social functioning (Fett et al., 2011). One of the most studied domains of social
cognition is affect recognition. It has been well established that individuals with
schizophrenia demonstrate stable deficits in both discrimination and identification of affect
irrespective of modality, facial (Addington et al., 2006a, Horan et al., in press; Pinkham et
al., 2007) or prosodic (Edwards et al., 2001; Kucharska-Pietura et al., 2005), and across all
stages of illness (Green et al., in press). Similar deficits in affect recognition have been
observed in individuals who are putatively prodromal for psychosis, i.e., at clinical high risk
(CHR) of developing a psychotic disorder. CHR individuals, relative to healthy controls,
have demonstrated impaired performance on facial affect identification comparable to the
performance of individuals with a first episode of psychosis and those who have a more
chronic course of psychosis (Addington et al., 2008; Green et al., 2011). Amminger et al
(Amminger et al., in press), using both a facial affect task as well as a measure of affective
prosody, reported similar results relative to healthy controls and first episode patients; CHR
individuals exhibited deficits in the recognition of fear and sadness across both face and
voice modalities compared to non-psychiatric controls.
Although these studies suggest that affect recognition deficits may be a traitcharacteristic,
there are no longitudinal studies testing the stability of affect recognition in those at clinical
high risk or examining its relationship to conversion to psychosis. The aim of this project
was to examine longitudinally affect processing in a large sample of individuals at CHR of
psychosis, to determine if affect processing was a predictor of later conversion to psychosis
and to determine if deficits in affect processing were unique to those who met established
criteria for a prodromal syndrome.
2. Method
2.1. Sample
The overall sample consisted of 172 individuals (98 males, 74 females) at CHR of psychosis
with a mean age of 19.8 (SD= 4.5) years and 100 help-seeking individuals, the help-seeking
controls (HSC) (56 males, 44 females) with a mean age of 19.4 (SD= 3.9) years. All were
participants in the PREDICT study that was conducted at the Universities of Toronto (70
CHR, 45 HSC), North Carolina (62 CHR, 31 HSC) and Yale (40 CHR, 24 HSC). PREDICT
was designed to determine predictors of conversion to psychosis. All CHR individuals met
the Criteria of Prodromal States (COPS) based on the Structured Interview for Prodromal
Symptoms (SIPS) (McGlashan et al., 2010). Participants were excluded if they were using
antipsychotics at baseline. Furthermore, antipsychotics were not used at any later points in
this study. One hundred and sixty-eight CHR participants met attenuated positive symptom
syndrome (APSS) criteria, which include the emergence or worsening of a non-psychotic
level disturbance in thought content, thought process or perceptual abnormality over the past
year. Four participants met criteria for genetic risk and deterioration (GRD), which required
either a first degree relative with a psychotic disorder or the subject having schizotypal
personality disorder (SPD) plus at least a 30% drop in functioning on the General
Assessment of Functioning (GAF) scale in the past 12 months. The HSC group were
individuals who had (i) responded to recruitment efforts for the CHR sample, and (ii) on a
phone screen appeared likely to meet prodromal criteria but after the initial comprehensive
Addington et al. Page 2
Schizophr Res. Author manuscript; available in PMC 2013 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
interview did not. The HSC group consisted of the following groups: (i) family high risk but
no decline in functioning (n= 17), (ii) long standing symptoms i.e. attenuated positive
symptoms had been present for more than one year (n= 47), current prodromal symptoms
but symptoms were clearly due to another disorder (n= 2), (iii) only had negative symptoms
(n= 4) and (iv) the remaining group reported vague symptoms that neither met severity nor
frequency (n= 30). Those with longstanding symptoms were individuals who had attenuated
psychotic symptoms that had begun or worsened more than a year before and were rated 3–5
on severity on the Scale of Prodromal Symptoms (SOPS). This severity is within the
prodromal range, but to meet prodromal criteria attenuated symptoms have to have begun or
worsened in the past year.
The Structured Clinical Interview for DSM-IV (SCID-I) (First et al., 1995) was used to
determine the presence of any axis I disorders. Participants were excluded if they met
criteria for any current or lifetime axis I psychotic disorder, prior history of treatment with
an antipsychotic, or past or current history of a clinically significant central nervous system
disorder which may confound or contribute to clinical high risk symptoms. A
comprehensive clinical assessment was conducted by the PI or clinical psychiatrist or
psychologist at each site to determine if entry criteria were met. Only 146 of the CHR
participants and 85 of the HSC completed the affect recognition tasks. In addition, since this
longitudinal study lasted for four years, the first person recruited could have had four years
of follow-up whereas the last person may have only had 3 months. Therefore at each follow-
up, missing subjects are accounted for either by conversion to psychosis, missing the
assessment, dropping out of the study or not being in the study long enough to reach that
particular follow-up. See Table 1.
2.2 Measures
Criteria for a prodromal syndrome and criteria for conversion to psychosis were determined
using the Structured Interview for Prodromal Syndromes (SIPS) (McGlashan et al., 2010).
Conversion meant that at least one of the five attenuated positive symptoms reached a
psychotic level of intensity (rated 6) for a frequency of ≥ 1 hour/day for 4 days/week during
the past month or that symptoms seriously impacting functioning (e.g. severely disorganised
or dangerous to self or others) (McGlashan et al., 2010). Symptoms were assessed with the
Scale of Prodromal Symptoms (SOPS), which consists of 19 items in 4 symptom domains:
positive, negative, general and disorganized. Intelligence was assessed using the Block
design, Arithmetic, Digit Symbol/Coding, Vocabulary and Information subtests from the
Wechsler Adult Intelligence Test (WAIS)/Wechsler Intelligence Scale for Children-III
(WISC-III) (Wechsler, 1974; 1981).
Facial affect recognition was assessed with the Facial Emotion Identification Test (FEIT)
and the Facial Emotion Discrimination Test (FEDT) (Kerr and Neale, 1993). These
measures have been described in detail elsewhere (Addington et al., 2008). Affective
prosody (AP) was assessed using a task developed by Edwards and colleagues (Edwards et
al., 2001) and used in the Amminger study (Amminger et al., in press). The task involves
audio recordings of 4 simple sentences (i.e. “he will come soon”, “they must stay here”, “she
will drive fast” and “we must go there”) spoken by three professional actors displaying
following emotions: fear, sadness, anger, surprise and neutral resulting in a total of 60 items.
Based on sentence recordings participants were required to indicate which emotion was
expressed. For each actor, there were 3 practice and 20 target items, with eight seconds of
silence between each item. Published reliability coefficients (Chronbach’s alpha) for AP is
0.85 (Edwards et al., 2001), for FEDT is 0.68, (Pinkham and Penn, 2006) and FEIT is 0.50
(Pinkham and Penn, 2006).
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2.3 Procedures
This was a longitudinal study of predictors of conversion to psychosis whereby all three
sites recruited CHR and HS individuals. Raters were experienced research clinicians who
demonstrated adequate reliability at routine reliability checks. Gold standard post-training
agreement on the distinction between high risk and psychotic levels of intensity on the
positive symptom items (i.e., the critical threshold for determining initial eligibility and
subsequent conversion status) was excellent (kappa= 0.90). The DSM-IV diagnoses were
made using the SCID-I. Interrater reliability was determined at the start of the study and
annually by 100% agreement on the diagnosis and at least 80% agreement for symptom
presence. JA chaired weekly conference calls to review criteria for all individuals admitted
to the study. Affect processing assessments were conducted by trained research assistants
trained by DLP. The study protocols and informed consents were reviewed and approved by
the ethical review boards of all three study sites.
2.4 Statistical Analyses
All analyses were performed with the use of IBM SPSS version 19 and SAS version 9.2.
The Student t-test and chi-square test were used to compare baseline differences between the
CHR group and the HS group and between the converters and the non-converters. Mann
Whitney U test was used to compare converters and non-converters given the unequal
sample sizes in the two groups. Spearman correlations were used to determine associations
amongst measures. To accommodate missing data and account for intra-participant
correlation over time, generalized linear mixed model for repeated measures was used to
examine changes over time (baseline, 6 months, 12 months, 18 months and 24 months) and
group differences for ratings on the three affect recognition measures.
3. Results
3.1 Sample Characteristics
There were no demographic differences between the CHR and HSC groups. Within the
CHR group there were no differences between those who converted and those who did not
convert within the time of the study. These results are presented in Table 2. The CHR group
had significantly higher ratings on attenuated positive symptoms and on general symptoms
on the SOPS compared to the HSC. These results are presented in Table 3. The groups were
also compared on IQ. There were no group differences (CHR, M= 111.65, SD= 17.13; HSC,
M= 110.75, SD= 19.99, t= −0.32).
Since there were a number of dropouts in this study, we compared those who dropped out on
demographics, IQ, three affect recognition tasks and symptoms. There were no differences
at any time between HSC who completed assessments and those who did not complete. For
the CHR participants who dropped out before one year those who dropped out had
significantly higher scores on the facial identification task (t=2.06 p<0.05). For those who
completed one year but not two years (n=8) compared to those who completed beyond one
year those who dropped out after one year had lower scores on facial affect discrimination
(t=3.56, p<0.01), less negative symptoms (t=2.65, p<0.1).
3.2 Affect recognition
In the HSC group, all three affect recognition tasks were significantly associated with one
another (Pearson’s correlation coefficient r ranged from 0.31–0.35, all p< 0.001). In the
CHR group, the facial affect identification and discrimination tasks were associated (r= 0.2,
p< 0.05) and the facial affect identification task was significantly related to the prosody task
(r= 0.36, p< 0.001). There were some associations amongst the affect recognition tasks and
symptoms. Interestingly, none of the tasks were associated with positive symptoms in either
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group. See Table 4. Table 5 presents the means and SDs for each affect task for each group.
In this table we have also presented means from healthy control groups published in the
literature (Addington et al., 2006; Edwards et al., 2001; Kee et al., 2004; Mueser et al.,
1996; Pinkham and Penn, 2006; Salem et el., 1996).
Results of the mixed effects modelling demonstrated that there were no differences between
the CHR and the HSC group on affect recognition tasks at baseline or any of the follow up
assessments. However, for the HSC group, there was a significant improvement on all affect
tasks by 24 months. For the CHR group, improvement occurred on two of the tasks by 6
months and on one task again at 24 months. However, since there is a significant loss of data
at 18 and 24 months we tested these results running the mixed effects model up to 12
months only. The only change was that for the CHR group there was a significant change in
the FEIT from baseline to 6 months (p=0.22) where as previously this had not been
significant (p=0.057). These results are presented in Table 6.
At baseline we examined the differences between the CHR and HSC groups on the
individual emotions within the prosody task and there were no significant differences.
Within the first 2 years of the study 25 participants in the CHR group, 13 males and 12
females, converted to psychosis. There were no differences between those who converted
and those who did not convert to psychosis on any of the three affect recognition tasks at
baseline. For those who converted there were no changes over time on any of the affect
recognition tasks.
Discussion
This is one of the first studies to longitudinally examine affect processing and its
relationship to later conversion to psychosis in a group of people at high risk of developing
psychosis. In this study, we did not have a healthy control group, thus we cannot definitely
say that our CHR sample demonstrated affect recognition deficits relative to healthy
controls. However, an earlier publication (Addington et al., 2008) demonstrated that a
subsample of 85 CHR individuals had significant deficits relative to healthy controls on the
facial affect identification task and performed similarly to those with an established
psychotic illness. With respect to the prosody task, our samples had scores that fell in the
same range as those of clinical samples with schizophrenia and other psychoses in Edwards
et al’s study (Edwards et al., 2001). We have reported results from other studies which
suggest that our sample of individuals at CHR of psychosis most likely have deficits in
affect processing with respect to facial affect identification and affective prosody.
Interestingly, the performance of the HSC group was indistinguishable from those at CHR.
There was no difference in performance on the three measures at baseline between those
who did and did not develop psychosis. Those at CHR showed some improvement at 6
months and for those who remained in the study at 24 months there was some evidence of
improved performance.
There are some limitations to this study. The follow-up sample is small due to the time line
of the study. The number of conversions is approximately 17% by 2 years which is an
average of what has been reported in the literature (Yung et al., 2008) and since all
participants did not reach the one year mark, there may be more potential converters. Our
assessment of social cognition was limited to affect processing and it may be that an
assessment of other domains of social cognition would have had different results. However,
with respect to psychotic disorders, affect processing is one of the best studied and robust of
the domains of social cognition (Kohler et al., 2010; Hoekert et al., 2007). We did not
observe any differences between the groups on individual emotions nor did any of the
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individual emotions predict conversion to psychosis. The strengths of the current study are
its longitudinal, prospective design, large initial sample, examination of two modalities of
affect processing as a predictor to later conversion to psychosis and the fact that the sample
was free of antipsychotics.
Thus, our results suggest that poorer performance on social cognition may be indicative of
being potentially vulnerable to developing psychosis but not necessarily a marker of
developing a full blown psychotic illness. This fits with the suggestion that there is a
continuum of psychosis from psychotic like–experiences to subclinical psychotic symptoms
to psychosis (van Os et al., 2009). Thus, difficulties in processing affect information may be
a problem for those who report psychotic-like-experiences or fluctuating subclinical
psychotic symptoms, or subthreshold symptoms regardless of whether they meet criteria for
a putative prodrome experience. In fact a recent internet-based, general population study
demonstrated that individual differences in psychosis-proneness were associated with the
ability to process facial affect (Germine and Hooker, 2011). Germine et al., (Germine et al.,
2011) further demonstrated that in individuals who rated high on social anhedonia, there was
less neural activity in brain regions thought to be implicated in facial emotion processing. In
addition there is evidence of deficits in affect recognition in those who are at family high
risk (Kee et al, 2004).
However, we cannot entirely rule out the predictive role of affect processing for conversion
to psychosis. The number of converters was small and approximately half of the conversions
occurred in the first 6 months of the study. Of those who converted after 6 months and had
at least one follow-up pre-conversion, statistically, there was no significant change in their
scores over time. Furthermore, a visual examination of their scores revealed that a few had
declining scores and a few had scores that varied only by one or two points over time. This
is the difficulty when focusing only on average performance.
Thus, it is likely that these individuals at high risk of psychosis, regardless of their level of
vulnerability (i.e., meeting criteria for a syndrome), have persistent difficulties with affect
processing. For those who do not go on to develop a psychotic illness, there seems to be
some improvement over time, but for those who do develop a psychotic illness the
difficulties may persist. Since the field of social cognition needs further work, particularly
with respect to norms of the many measures that are used, we are unable to determine the
level of improvement that may be occurring.
Our results may have important implications for social functioning since the ability to
accurately recognize emotion is fundamental to social functioning. Difficulties in affect
recognition as well as other aspects of social cognition are consistently associated with poor
social functioning (Fett et al., 2011) and have been reported to be the best predictor of social
functioning in schizophrenia even when compared with other cognitive tasks (Hooker and
Park, 2002). A number of studies of individuals at CHR have reported deficits in functioning
(Addington et al. 2008; Cornblatt et al., in press) and that social deficits may be predictive of
conversion to later psychosis (Cornblatt et al., in press). Thus, although poor affect
processing may exist in CHR samples and does not independently predict conversion, it
does relate to functioning, which in turn has been reported to predict conversion.
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Table 3
SOPS Symptom Ratings for Clinical High Risk and Help Seeking Control Groups
Symptom
subscores
CHR
(N= 172)
M (SD)
HSC
(N= 100)
M (SD) t- value
Positive 11.02 (3.20) 6.53 (4.15) −9.31***
Negative 8.61 (5.66) 8.38 (6.30) −0.30
Disorganised 4.11 (2.75) 3.68 (3.16) −1.18
General 7.02 (3.91) 5.19 (4.11) −3.64***
***
p≤ 0.001
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Table 4
Correlations between SOPS Symptoms and Affect Recognition at Baseline
Clinical High Risk
Positive Negative Disorganised General
FEDT 0.11 0.02 −0.03 −0.01
FEIT −0.01 −0.27** −0.17 −0.14
AP −0.09 −0.22** −0.12 −0.01
Help-seeking Controls
FEDT −0.13 −0.07 −0.13 −0.07
FEIT −0.03 −0.11 −0.03 −0.02
AP −0.08 −0.38** −0.33** 0.01
Note: all correlations are Spearman’s rho coefficients;
**
p< 0.007 following Bonferroni correction FEIT=Facial Affect Identification Test; FEDT= Facial Affect Discrimination Test; AP= Affect
Prosody
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